Viridian Therapeutics, Inc. VRDN Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $176.35M-17.0% | $212.38M+25.2% | $169.65M+44.6% | $117.32M+1.0% | $116.22M+16.7% | ||
| $585.84M-11.5% | $662.27M+106% | $321.25M-28.0% | $446.03M-14.3% | $520.42M-15.8% | ||
| $22.56M+15.2% | $19.58M+77.8% | $11.01M-28.5% | $15.39M-25.3% | $20.61M-1.3% | ||
| —— | —— | —— | —— | —— | ||
| $784.74M-12.2% | $894.23M+56.4% | $571.91M-1.2% | $578.75M-11.9% | $657.24M-11.0% | ||
| $1.13M-8.0% | $1.23M+9.2% | $1.13M+3.1% | $1.09M-6.1% | $1.16M-6.0% | ||
| $2.26M-6.9% | $2.42M+2,631,521,639% | $0.09-1.1% | $0.090.0% | $0.09-100.0% | ||
| $888K-42.2% | $1.54M+1.2% | $1.52M+200% | $506K+3.5% | $489K-2.4% | ||
| $789.02M-12.3% | $899.42M+55.8% | $577.14M-0.9% | $582.32M-11.9% | $660.98M-11.0% | ||
| $13.31M+53.3% | $8.68M-13.7% | $10.06M+18.1% | $8.52M+119% | $3.89M+81.3% | ||
| $8.36M-57.5% | $19.66M+83.5% | $10.71M+30.9% | $8.19M+60.6% | $5.1M-88.9% | ||
| $274K-25.3% | $367K-1.3% | $372K+29.2% | $288K0.0% | $288K0.0% | ||
| $738K-2.0% | $753K+3.2% | $730K+32.0% | $553K+3.2% | $536K+4.5% | ||
| $385K0.0% | $385K+158% | $149K0.0% | $149K-3.2% | $154K0.0% | ||
| $51.81M-26.7% | $70.7M+39.5% | $50.7M-3.6% | $52.59M+55.9% | $33.73M-29.6% | ||
| $36.09M+5.4% | $34.24M+63.9% | $20.89M+69.1% | $12.35M-40.3% | $20.69M— | ||
| $2.18M-7.0% | $2.34M-9.3% | $2.58M+24.3% | $2.08M+10.2% | $1.88M-18.4% | ||
| $12.5M-37.6% | $20.03M-73.0% | $74.17M+10.4% | $67.16M+18.8% | $56.51M-20.1% | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M+24,591% | ||
| $1.95B+1.0% | $1.93B+25.9% | $1.53B+1.5% | $1.51B+0.8% | $1.5B+1.3% | ||
| -$1.44B-7.8% | -$1.34B-9.9% | -$1.22B-2.9% | -$1.18B-9.3% | -$1.08B-8.7% | ||
| -$558K-225% | $447K+23.1% | $363K+426% | $69K-71.8% | $245K+2,550% | ||
| $636.01M-11.9% | $722.17M+43.6% | $502.97M-2.4% | $515.17M-14.8% | $604.47M-10.0% | ||
| $789.02M-12.3% | $899.42M+55.8% | $577.14M-0.9% | $582.32M-11.9% | $660.98M-11.0% | ||
| $586.4M-11.4% | $661.82M+37.6% | $481.07M-13.0% | $552.69M-12.0% | $627.85M-12.1% | ||
| $585.84M-11.5% | $662.27M+37.6% | $481.43M-12.9% | $552.76M-12.0% | $628.09M-12.0% | ||
| $585.84M-11.5% | $662.27M+106% | $321.25M-28.0% | $446.03M-14.3% | $520.42M-15.8% | ||
| —— | —— | —— | —— | —— | ||
| $888K-42.2% | $1.54M+1.2% | $1.52M+200% | $506K+3.5% | $489K-2.4% | ||
| $586.4M-11.4% | $661.82M+37.6% | $481.07M-13.0% | $552.69M-12.0% | $627.85M-12.1% | ||
| $2.26M-6.9% | $2.42M-6.2% | $2.58M+30.6% | $1.98M-5.5% | $2.09M-5.1% | ||
| $2.26M-6.9% | $2.42M-6.2% | $2.58M+30.6% | $1.98M-5.5% | $2.09M-5.1% | ||
| $888K-42.2% | $1.54M+1.2% | $1.52M+200% | $506K+3.5% | $489K-2.4% | ||
| $2.26M-6.9% | $2.42M-6.2% | $2.58M+30.6% | $1.98M-5.5% | $2.09M-5.1% | ||
| $888K-42.2% | $1.54M+1.2% | $1.52M+200% | $506K+3.5% | $489K-2.4% | ||
| $8.36M-57.5% | $19.66M+83.5% | $10.71M+30.9% | $8.19M+60.6% | $5.1M-52.1% | ||
| $38.49M-37.9% | $62.01M+52.6% | $40.63M+15.0% | $35.34M+19.6% | $29.55M-35.4% | ||
| $38.49M-37.9% | $62.01M+52.6% | $40.63M+15.0% | $35.34M+19.6% | $29.55M-35.4% | ||
| $8.36M-57.5% | $19.66M+83.5% | $10.71M+30.9% | $8.19M+60.6% | $5.1M-52.1% | ||
| —— | —— | —— | —— | —— | ||
| $5.35M+39.8% | $3.83M-8.4% | $4.18M+97.3% | $2.12M+36.3% | $1.55M-33.1% | ||
| —— | —— | —— | —— | —— | ||
| $36.83M-0.3% | $36.96M+55.4% | $23.78M+3.0% | $23.08M-0.1% | $23.11M+811% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| 102.5M+0.6% | 101.8M+23.8% | 82.2M+0.7% | 81.7M+0.1% | 81.6M+0.7% | ||
| $1.03M+0.7% | $1.02M+23.8% | $822K+0.6% | $817K+0.1% | $816K+0.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $52K-89.5% | $495K+26.9% | $390K+41.3% | $276K-47.2% | $523K-6.1% | ||
| $612K+1,175% | $48K+77.8% | $27K-86.9% | $206K-25.9% | $278K-51.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $5.35M+39.8% | $3.83M-8.4% | $4.18M+97.3% | $2.12M+36.3% | $1.55M-33.1% | ||
| $612K+1,175% | $48K+77.8% | $27K-86.9% | $206K-25.9% | $278K-51.0% | ||
| $52K-89.5% | $495K+26.9% | $390K+41.3% | $276K-47.2% | $523K-6.1% | ||
| $586.4M-11.4% | $661.82M+37.6% | $481.07M-13.0% | $552.69M-12.0% | $627.85M-12.1% | ||
| $585.84M-11.5% | $662.27M+37.6% | $481.43M-12.9% | $552.76M-12.0% | $628.09M-12.0% | ||
| $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | $0.010.0% | ||
| $200M0.0% | $200M0.0% | $200M0.0% | $200M0.0% | $200M0.0% | ||
| $102.46M+0.6% | $101.83M+23.8% | $82.23M+0.7% | $81.65M+0.1% | $81.59M+0.7% | ||
| $102.46M+0.6% | $101.83M+23.8% | $82.23M+0.7% | $81.65M+0.1% | $81.59M+0.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $568K-76.7% | $2.44M+32.8% | $1.84M+167% | $688K+31.5% | $523K-39.2% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Viridian Therapeutics, Inc.'s total assets?
- Viridian Therapeutics, Inc. (VRDN) holds $789.0M in total assets, up 19.4% year over year.
- How much debt does Viridian Therapeutics, Inc. have?
- Viridian Therapeutics, Inc. carries $36.8M in total debt against $636.0M of shareholders' equity, a debt-to-equity ratio of 0.06.
- How much cash does Viridian Therapeutics, Inc. have?
- Viridian Therapeutics, Inc. holds $176.3M in cash and equivalents.
- Can Viridian Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 15.15 — current assets exceed current liabilities.
- Where does Viridian Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Viridian Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
